Steve Jackson 2020 recipient of the Royal Society Mullard Award

Steve Jackson has been awarded  the Royal Society Mullard Award for his pioneering research on DNA repair mechanisms and synthetic lethality that led to the discovery of olaparib, which has reached blockbuster status for the treatment of ovarian and breast cancers. Steve said “It is a great honour to receive the Royal Society Mullard Award in recognition of how my research has helped pave the way for new cancer therapies. This achievement has, of course, only been possible because of the dedication and efforts of a great many people who have worked to translate concepts and findings arising from fundamental discoveries made in my academic group through drug discovery and drug development.  It is wonderful to see how these efforts have nurtured biotech and pharmaceutical companies; and have led to a drug that is extending and enhancing the lives of cancer patients throughout the world. “